It was inevitable, KFC in the United Kingdom has today officially joined the vegan bandwagon by offering people the chance to try “The Imposter”, which is a Quorn fillet with vegan mayo and the usual lettuce and tomato fillers you’d find in a crispy chicken burger.
This is surely in order to attract the growing number of young vegan eaters looking for junk food alternatives that don’t contain any animal by-products in them. A savvy business move which might be interpreted as a gamble like the one you might find on Mohegan sun casino but no doubt which will make them a hefty profit as vegans have been lobbying the KFC headquarters for years to introduce vegan options and better yet reduce their reliance on the need to offer their eaters chickens.

Dawn Carr, director of vegan corporate projects at PETA commented on the introduction of meat alternatives in the fast-food chain by saying that “we're confident it will be a huge hit with the skyrocketing numbers of vegans, vegetarians, and flexitarians around the United Kingdom".
The bad news for vegans looking to try it out just as soon as they read this article is that KFC decided to trial this new vegan offering at select restaurants for only a month, a somewhat dubious marketing move considering there is a huge demand for such meat alternatives across the UK already.
KFC is jumping on the meat-free bandwagon, launching a vegan version of its signature crispy chicken burger in the United Kingdom. This follows Burger King’s recent announcement that they will start offering the very popular Impossible burger as a Whopper option for vegan eaters. Again, this is not being rolled out all over the world but just in 100 or so locations in the San Francisco Bay Area in California, USA.
According to Euromonitor International, the meat substitutes market is going to grow globally to $23billion by 2023 from a market that is already worth $19billion in 2019.
This article does not necessarily reflect the opinions of the editors or management of EconoTimes.


Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Anta Sports Expands Global Footprint With Strategic Puma Stake
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Washington Post Publisher Will Lewis Steps Down After Layoffs
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 



